Close menu

December 23rd, 2021 | 12:05 CET

wallstreet:online AG, Palantir, AMC Entertainment - Still ahead in 2022!

  • Investments
Photo credits:

At the turn of the year, the stock markets are moody to fragile. Again and again, the prices are driven upwards. Even an announced interest rate increase in 2022 on the part of the FED is taken to set the prices further upwards. This is classic asset inflation! Many new market participants currently try their trader luck no matter what comes out of it. They have been experiencing a highly expansionary environment for the past 5 years, but speculation on rising prices can go awry in a new interest rate environment. Nevertheless, quality will always prevail on the stock market. We look at some interesting protagonists for this.

time to read: 4 minutes | Author: André Will-Laudien

Table of contents:

    wallstreet:online - Clear undervaluation of the financial platform

    The current broker test of the magazine Finanztest turned out very well for the wallstreet:online Group (W:O) in December 2021. The in-house trading platform "Smartbroker" was named the most favorable provider with the largest stock exchanges. This is precisely what the financial community needs: good trading quality, connection to forums and social media channels, and top financial information all in one. W:O combines trading and information for a community of over 830,000 users, which is unique in Europe.

    Smartbroker has positioned itself firmly in this environment, now manages more than 200,000 customer custody accounts and already significantly outperforms the competition with the average custody account size under management. The concept is well received, and now the active community is just waiting for the promised app. It is scheduled for launch in the first half of 2022 - another plus point for the attractiveness of the neobroker. Overall, according to management, assets under management should already reach the EUR 10 billion mark in the first half of 2022.

    To accelerate the growth of the Group, the parent company increased its stake in wallstreet:online capital AG by a further EUR 8 million as part of a capital increase. The Company already owns more than 95% of the subsidiary, which operates the Smartbroker. As part of a squeeze-out offer at the EGM in January 2022, the Company is attempting to integrate the remaining free shares into the Group at a cash settlement of EUR 47.48 per share.

    The outstanding position of the Group as an integrated information and trading platform is unique in Germany, so further steep growth is pre-programmed. If one compares the valuation of the entire W:O Group at EUR 327 million to the last rounds of Trade Republic or Scalable, then a clear undervaluation becomes apparent. The W:O share thus remains a favorite for the coming stock market year 2022.

    Palantir Technologies - The big wave seems to be over

    Palantir is one of the most scintillating US IPOs of 2020, with shares finally trading at USD 8.50 in September after some difficulties due to opaque lock-up rules. Demand for the "Made in Denver" data octopus was so great at the outset that the share price quintupled to over USD 44 in the first 3 months after listing. The price steadily declined until the end of 2021, but the current capitalization is still USD 37.4 billion - reflecting a 20-fold revenue valuation. What can we expect from 2022 onwards?

    According to analyst consensus, Palantir will grow its revenues from USD 1.2 billion to USD 3.3 billion between 2021 and 2025. That corresponds to a growth per annum (CAGR) of 28%. In 2023, there should already be the first net profit; operationally, the Company is already positive in 2021. The median price target of 8 experts is USD 23, which is around 22% above the current quotation.

    With a corridor of USD 18 to 26, the Palantir share is currently at the lower edge of the 9-month trading range. The stock is analytically very expensive (P/S 20 and P/B 16), yet with the expected growth, it is possible to grow into the valuation in 2 to 3 years. In a pronounced NASDAQ correction, the stock is well worth buying at a discount.

    AMC Entertainment - Spiderman pulls on the valuation

    For a long time, it had been believed that the so-called MEME stocks, i.e. stocks recommended for purchase via social networks, would eventually have to regain a standard valuation. Far from it, because the AMC Entertainment shares increased tenfold from a standing start with the initial squeeze movement between February and June 2021 and reached over EUR 60 in the summer of 2021. With 2020 sales of USD 1.2 billion, the American cinema operator was worth just under EUR 30 billion. At the time, there were no great growth prospects because of the pandemic.

    Now some calm has returned, but the speculative interest in the AMC share flared up again with the recently reported attendance figures for the new Spiderman movie. The market rewarded the strong demand at the box office with high turnover and a 30% share price increase.

    We take a fundamental look at AMC stock. As a result of the Corona Crisis, AMC's market share has increased by a quarter from pre-pandemic levels. The Company has also been able to refinance very well through three capital raises and has been buying up operations from competitors. As a result, one in three US theaters is now an AMC theater, and the Group is again expanding slightly. But beware: the price-to-sales ratio is an astronomical 6, and AMC Group did not generate net profits until 2023. The votes of 7 expert estimates are all Hold, Underweight or Sell - a Buy recommendation is probably only to be found on Reddit.

    In 2021, the stock market has shown severe undervaluations and overvaluations as part of daily business. FAANG or MEME stocks can take on whatever valuations they want because when in doubt, flashy individuals like Elon Musk tell the market how much their stock is worth. MEME stocks have a life of their own, and there are hardly any valuation approaches here. However, in the case of wallstreet:online AG, our vote is simple: Strong growth & undervalued!

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by André Will-Laudien on September 26th, 2023 | 07:45 CEST

    Artificial Intelligence in Sellout! Nvidia, Defense Metals, ARM Holdings - Nothing works without rare earths!

    • Mining
    • RareEarths
    • AI
    • chips
    • Investments

    After long bull market movements, the stock market usually tends to rotate sectors, or the market enters a general consolidation. In the former case, investors can profit by reallocating their assets while exploring new investment opportunities. In the latter case, all stocks come down, and the capital market generally suffers from a change in sentiment and corrects recently exaggerated valuations. In the case of the new megatrend of Artificial Intelligence (AI), the stock market seems to sense a great need for correction. As if by magic, the blockbuster stock Nvidia rose by 250% in just 9 months. However, it has already retraced nearly 20% from its peak. Where do the opportunities lie for investors?


    Commented by André Will-Laudien on September 22nd, 2023 | 07:20 CEST

    Recalculation! These are the bare figures: TUI, Saturn Oil + Gas, Deutsche Bank - Buy prices non-stop!

    • Mining
    • Oil
    • travel
    • Investments
    • Banking

    Companies do not always have good figures in their baggage. Analysts listen very carefully to the words of those in charge. Often, it is only a minor sentence that changes entire valuations. TUI is slowly approaching pre-COVID figures. Saturn Oil & Gas must backtrack slightly because of substantial forest fires in Alberta, and Deutsche Bank aims to finalize the Postbank project in 2023. All three stocks offer good buying opportunities because the long-term prospects are quite convincing.